Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases.
10.3802/jgo.2009.20.3.158
- Author:
Ali AYHAN
1
;
Mehmet Coskun SALMAN
;
Melih VELIPASAOGLU
;
Mehmet SAKINCI
;
Kunter YUCE
Author Information
1. Department of Obstetrics and Gynecology, Baskent University Faculty of Medicine, Ankara, Turkey.
- Publication Type:Original Article
- Keywords:
Ovarian granulosa cell tumors;
Prognostic factors;
Recurrence;
Mortality;
Survival
- MeSH:
Adult;
Female;
Follow-Up Studies;
Granulosa Cell Tumor;
Granulosa Cells;
Humans;
Multivariate Analysis;
Ovarian Neoplasms;
Prognosis;
Recurrence;
Retrospective Studies;
Uterine Hemorrhage
- From:Journal of Gynecologic Oncology
2009;20(3):158-163
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: Ovarian granulosa cell tumors are rare malignancies with a relatively favorable prognosis. However, patients still suffer from disease-related mortality. Therefore, the prognostic factors should be clarified. The purpose of this study was to investigate the clinical and pathologic characteristics related with disease recurrence and mortality in adult type ovarian granulosa cell tumors. METHODS: Eighty surgically staged patients with granulosa cell ovarian tumor treated at the Hacettepe University Hospital between 1982 and 2006 were retrospectively reviewed. Clinical and pathological characteristics were analyzed. RESULTS: Granulosa cell ovarian tumors accounted for 4.3% of malignant ovarian neoplasms. Mean age was 47.6 years. The most common presenting symptom was abnormal uterine bleeding (53.7%). Endometrial pathology was detected in 51.2% of patients preoperatively. Seventy percent of patients were diagnosed at stage I, and 53.8% of patients received adjuvant treatment. Mean follow-up was 67.5 months. Overall 5-year and 10-year survival was 91% and 86%, respectively. Mean survival was 147.1 months. Recurrence rate was 11.2%. In univariate analysis, advanced stage, advanced age, residual disease after surgery, and need for adjuvant treatment were associated with disease-related mortality and advanced stage disease and absence of initial staging surgery were associated with disease recurrence. However, in multivariate analysis, only initial stage was found to be a significant prognostic factor. CONCLUSION: Initial stage seems to be the single most important prognostic factor in ovarian granulosa cell tumors. Therefore, a comprehensive staging surgery should be attempted to document the real extent of disease and to estimate the oncologic outcome more accurately.
